STEPHEN E GOLDSTONE, MD
Radiology at 23 St, New York, NY
License number
New York 142871
Category
Radiology
Type
Surgery
Address
Address
420 WEST 23Rd St SUITE PB, New York, NY 10011
Phone
(212) 242-6500
(212) 242-3111 (Fax)
(212) 242-3111 (Fax)
Personal information
See more information about STEPHEN E GOLDSTONE at radaris.comName
Address
Phone
444 Central Park W APT 14A, New York, NY 10025
4 Old Hollow Ln, East Hampton, NY 11937
4 Old Hollow Ln, East Hampton, NY 11937
444 Central Park W, New York, NY 10025
Professional information
Physician At Dr. Stephen Goldstone
Location:
Greater New York City Area
Industry:
Medical Practice
Stephen Elliot Goldstone, New York NY
Specialties:
Surgeon
Address:
420 W 23Rd St, New York, NY 10011
Education:
Yeshiva University, Albert Einstein College of Medicine - Doctor of Medicine
Board certifications:
American Board of Surgery Certification in Surgery
Dr. Stephen E Goldstone, New York NY - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
Laser Surgery Care
420 W 23Rd St, New York 10011
(212) 242-6500 (Phone)
420 W 23Rd St, New York 10011
(212) 242-6500 (Phone)
Certifications:
General Surgery, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albert Einstein College Of Medicine Of Yeshiva University
Graduated: 1979
Albert Einstein Coll Med
Albert Einstein College Of Medicine Of Yeshiva University
Graduated: 1979
Albert Einstein Coll Med
Human Papilloma Virus Treatment
US Patent:
2003017, Sep 11, 2003
Filed:
Feb 13, 2003
Appl. No.:
10/365908
Inventors:
John Neefe - Devon PA, US
Stephen Goldstone - New York NY, US
Mark Winnett - Phoenixville PA, US
Marvin Siegel - Blue Bell PA, US
Leslie Boux - Victoria, CA
Stephen Goldstone - New York NY, US
Mark Winnett - Phoenixville PA, US
Marvin Siegel - Blue Bell PA, US
Leslie Boux - Victoria, CA
Assignee:
Stressgen Biotechnologies Corporation, a Canadian corporation
International Classification:
C07H021/04, A61K039/295, A61K047/00, A61K045/00
US Classification:
424/201100, 424/278100, 424/204100, 536/023720
Abstract:
Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
Human Papilloma Virus Treatment
US Patent:
2002011, Aug 15, 2002
Filed:
Jun 26, 2001
Appl. No.:
09/891823
Inventors:
John Neefe - Devon PA, US
Stephen Goldstone - New York NY, US
Mark Winnett - Phoenixville PA, US
Marvin Siegel - Blue Bell PA, US
Leslie Boux - Victoria, CA
Stephen Goldstone - New York NY, US
Mark Winnett - Phoenixville PA, US
Marvin Siegel - Blue Bell PA, US
Leslie Boux - Victoria, CA
International Classification:
A61K039/12
US Classification:
424/204100
Abstract:
Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
Human Papilloma Virus Treatment
US Patent:
7754449, Jul 13, 2010
Filed:
Apr 26, 2007
Appl. No.:
11/796144
Inventors:
John R. Neefe - Devon PA, US
Stephen E. Goldstone - New York NY, US
Mark T. Winnett - Phoenixville PA, US
Marvin Siegel - Blue Bell PA, US
Leslie J. Boux - Victoria, CA
Stephen E. Goldstone - New York NY, US
Mark T. Winnett - Phoenixville PA, US
Marvin Siegel - Blue Bell PA, US
Leslie J. Boux - Victoria, CA
Assignee:
Nventa Biopharmaceuticals Corporation - La Jolla CA
International Classification:
C12P 21/06
US Classification:
435 691
Abstract:
Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
Human Papilloma Virus Treatment
US Patent:
7211411, May 1, 2007
Filed:
Jun 18, 2004
Appl. No.:
10/871138
Inventors:
John R. Neefe - Devon PA, US
Stephen E. Goldstone - New York NY, US
Mark T. Winnett - Phoenixville PA, US
Marvin Siegel - Blue Bell PA, US
Leslie J. Boux - Victoria, CA
Stephen E. Goldstone - New York NY, US
Mark T. Winnett - Phoenixville PA, US
Marvin Siegel - Blue Bell PA, US
Leslie J. Boux - Victoria, CA
Assignee:
Nventa Biopharmaceuticals Corporation - Victoria
International Classification:
C12P 21/06
US Classification:
435 691, 435 697, 4241921, 4242041
Abstract:
Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.